Connective Portfolio Management, LLC Vertex Pharmaceuticals Inc Transaction History

Connective Portfolio Management, LLC

  • $62.5 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024
BUY
$460.0 - $505.78 $4.19 Million - $4.61 Million
9,110 Added 227.75%
13,110 $6.1 Million
Q2 2024

Jul 30, 2024
BUY
$392.81 - $485.53 $589,215 - $728,295
1,500 Added 60.0%
4,000 $1.87 Million
Q1 2024

Apr 30, 2024
BUY
$407.69 - $446.08 $1.02 Million - $1.12 Million
2,500 New
2,500 $1.05 Million

Others Institutions Holding VRTX

# of Institutions
1,764
Shares Held
222M
Call Options Held
1.63M
Put Options Held
1.47M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $131B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Connective Portfolio Management, LLC Portfolio

Follow Connective Portfolio Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connective Portfolio Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Connective Portfolio Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email